Safety and Tolerability of Repeat Courses of IM Alefacept
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether repeat courses of alefacept, administered
intramuscularly, are safe when given to chronic plaque psoriasis patients who are receiving
standard dermatology treatments.